About LEMS
Lambert-Eaton myasthenic syndrome (LEMS) is a disorder of the neuromuscular junction8
Neuromuscular junction (NMJ) disorders may be the result of exposure to certain toxins, immune-mediated diseases, or genetic disorders.8
While all neuromuscular junction disorders are uncommon, the immune-mediated diseases—
LEMS and MG—are the ones most often encountered in the EMG lab.8
KEY FACTS ABOUT LEMS
Symptoms
LEMS is a rare, immune-mediated neuromuscular disorder characterized by a clinical triad of signs and symptoms: proximal muscle weakness, autonomic symptoms, and hyporeflexia or areflexia.12 See more on the LEMS Symptoms Map.
Burden
LEMS results in diminished physical functionality as well as impairments in activities of daily living (ADL) and patients’ quality of life.5
Prevalence
LEMS is estimated to affect up to 3,000 individuals in the United States11—up to 58% of whom are previously diagnosed with another condition12
COMORBIDITY
Historically, more than half of LEMS cases are associated with an underlying cancer, usually small cell lung cancer (SCLC).13 Studies suggest that LEMS patients with SCLC display a more rapidly progressing course of disease vs those with LEMS not associated with SCLC.14,15 Because LEMS symptoms often precede tumor detection by months or even years16, LEMS patients’ lives may be saved by earlier diagnosis and treatment of the cancer.
PATHOPHYSIOLOGY
LEMS is caused by autoantibodies to presynaptic voltage-gated calcium channels (VGCCs) that reduce the release of acetylcholine into the NMJ, inhibiting neuromuscular transmission.17-19
DISEASE BURDEN
Progression of LEMS symptoms contributes to worsening disease burden5
IN A 2012 SURVEY OF PATIENTS LIVING WITH LEMS5:
75% reported partial or total restriction of activities of daily living5, such as rising from a chair or climbing stairs6
50% reported severe leg weakness; other frequently reported symptoms included dry mouth and difficulty focusing eyesight5
Based on EQ-5D scores, the health-related quality of life for LEMS patients is comparable to the most severe forms of multiple sclerosis5
In a 2001 study, ~25% of LEMS patients required a wheelchair all the time or for mobilization outside the home20
A CHALLENGING DIAGNOSIS
LEMS patients often experience a long diagnostic journey5
REASONS FOR THE DELAYS IN DIAGNOSIS:
- Nonspecific and fluctuating symptoms12
- Slow progression of disease12
- Similar clinical presentation to other conditions12,21
Despite the significant burden it places on patients and their families, LEMS is often underrecognized5
THE DIAGNOSTIC CONUNDRUM
Studies reveal that more than half of patients with LEMS received a different diagnosis first12,21
In a cohort of 241 adult patients with LEMS, 58% were diagnosed with another disorder at least once before receiving the correct diagnosis.12
Clinical presentation of LEMS resembles other common diagnoses12,21
The symptoms of LEMS are often mistaken for common diseases and disorders, such as myasthenia gravis (MG), multiple sclerosis (MS), Guillain-Barré syndrome, amyotrophic lateral sclerosis (ALS), and depression.12,21
INITIAL DIAGNOSES PRIOR TO CONFIRMATION OF LEMS (n=140)12
- MG
- Muscular abnormalities
- Peripheral nerve abnormalities
- Intracranial/spinal cord abnormalities
- Depression
- Other
More than 1/3 of LEMS patients were previously diagnosed as having MG12
Prevalence of misdiagnoses among patients with LEMS12
- MG
- Muscular abnormalities
- Peripheral nerve abnormalities
- Intracranial/spinal cord abnormalities
- Depression
- Other
More than 1/3 of LEMS patients were previously diagnosed as having MG12
Watch Expert Videos
Learn more about LEMS diagnosis and treatment by visiting our LEMS Video Library.